Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Miami FL,
Sponsor: Housey Healthcare ULC
Sex: All
Age: 18+
Code: NCT07546929
Phase 2, Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Boston MA, Hackensack NJ, New Brunswick NJ,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase 2, Recruiting
Vitamin K for Perioperative Warfarin Management
for
Anticoagulant Therapy
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT07515664
Recruiting
ADAPT Micro-Randomized Trial
for
Cardiovascular Diseases
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT06915220
Recruiting
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
for
Parkinson Disease, Parkinson Disease Dementia
Location: Ann Arbor MI
Sponsor: Prabesh Kanel
Sex: All
Age: 45+
Code: NCT07154511
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
for
AMI Cardiogenic Shock
Location: Boston MA, Falls Church VA, Naples FL, Detroit MI,
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT06964685
Recruiting
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
for
Necrotizing Fascitis
Location: Lebanon NH, Philadelphia PA, Atlanta GA, Ann Arbor MI,
Sponsor: Eric R. Henderson
Sex: All
Age: 18+
Code: NCT06877793
Recruiting
Advancing Decisions About Virtual Service Encounters
for
Health Care Costs, Delivery of Health Care
Location: Ann Arbor MI
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06539988
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Portsmouth VA, Norfolk VA, Bethesda MD, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 45 - 70+
Code: NCT06995898
Recruiting
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
for
Breast Cancer
Location: Boston MA, Wellesley Hills MA, New York NY, Sewell NJ,
Sponsor: American College of Radiology
Sex: Female
Age: 45 - 70+
Code: NCT05625659
Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: New Brunswick NJ, Florham Park NJ, Tampa FL, Canton OH,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase 2, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Tamarac FL, Cooper City FL, Miami FL, Tampa FL, Troy MI,
Sponsor: EMD Serono Research & Development Institute, Inc.
Location: Smithfield NC, Hollywood FL, Fort Lauderdale FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07355218
Phase 3, Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Westbury NY, New York NY, Midlothian VA, Plantation FL,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase 2, Phase 3, Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
Comparing Single-Session Therapies for Chronic Pain
for
Chronic Musculoskeletal Pain
Location: Detroit MI, Chicago IL
Sponsor: Mark A. Lumley
Sex: All
Age: 18+
Code: NCT07008105
Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Atlanta GA,